Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay AreaOctober 4, 2021 There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay Area